Due to the heterogeneity of stromal cell populations, SHH signaling in CAFs, which can support tumor promotion, in some CAFs may be responsible as well for tumor differentiation, immune surveillance, T-cell immunity, decreased angiogenesis, and αSMA-expression [467,498,499,500,501,502]. This evidence concerns the gene ACTA1 and neoplasm.